Carrie Saunders

Carrie Saunders

Auto-generated profile, based on publicly available information

Carrie Saunders

Duke Human Vaccine Institute, Duke University Medical Center, Durham, USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
RHRory Henderson
Rory Henderson
KAKara Anasti
Kara Anasti
KMKartik Manne
Kartik Manne
VSVictoria Stalls
Victoria Stalls
CSCarrie Saunders
Carrie Saunders
BHBarton F. Haynes
Barton F. Haynes
Vaccine development targeting rapidly evolving pathogens such as HIV-1 requires induction of broadly neutralizing antibodies (bnAbs) with conserved paratopes and mutations, and in some cases, the same Ig-heavy chains. The current trial-and-error search for immunogen modifications that improve selection for specific bnAb mutations is imprecise. Here, to precisely engineer bnAb boosting immunogens, we use molecular dynamics simulations to examine encounter states that form when antibodies collide with the HIV-1 Envelope (Env). By mapping how bnAbs use encounter states to find their bound states, we identify Env mutations predicted to select for specific antibody mutations in two HIV-1 bnAb B cell lineages. The Env mutations encode antibody affinity gains and select for desired antibody mutations in vivo. These results demonstrate proof-of-concept that Env immunogens can be designed to directly select for specific antibody mutations at residue-level precision by vaccination, thus demonstrating the feasibility of sequential bnAb-inducing HIV-1 vaccine design.

2 February 2024 in Science Advances
Verified
Journal Article
Open access
ABAshley Bennett
Ashley Bennett
RERobert Edwards
Robert Edwards
IKIrina Kosheleva
Irina Kosheleva
CSCarrie Saunders
Carrie Saunders
YBYishak Bililign
Yishak Bililign
RHRory Henderson
Rory Henderson
The HIV-1 Envelope (Env) glycoprotein facilitates host cell fusion through a complex series of receptor-induced structural changes. Although remarkable progress has been made in understanding the structures of various Env conformations, microsecond timescale dynamics have not been studied experimentally. Here, we used time-resolved, temperature-jump small-angle x-ray scattering to monitor structural rearrangements in an HIV-1 Env SOSIP ectodomain construct with microsecond precision. In two distinct Env variants, we detected a transition that correlated with known Env structure rearrangements with a time constant in the hundreds of microseconds range. A previously unknown structural transition was also observed, which occurred with a time constant below 10 μs, and involved an order-to-disorder transition in the trimer apex. Using this information, we engineered an Env SOSIP construct that locks the trimer in the prefusion closed state by connecting adjacent protomers via disulfides. Our findings show that the microsecond timescale structural dynamics play an essential role in controlling the Env conformation with impacts on vaccine design.